학술논문
Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib
Document Type
Article
Author
Source
In: Thoracic Research and Practice . (Thoracic Research and Practice, July 2023, 24(4):180-185)
Subject
Language
English
ISSN
29799139